¥3,470.00
1.14%
Tokyo, Fri, Sep 18 2026.
ISIN
JP3282750003
Symbol
9267

Genky Drugstores Co.,ltd. Target price 2026 - Analyst rating & recommendation

Genky Drugstores Co.,ltd. Classifications & Recommendation

Buy
86%
Hold
14%

Genky Drugstores Co.,ltd. Price Target

Target Price ¥5,100.00
Price ¥3,470.00
Potential
Number of Estimates 4
4 Analysts have issued a price target Genky Drugstores Co.,ltd. 2027 . The average Genky Drugstores Co.,ltd. target price is ¥5,100.00. This is higher than the current stock price. The highest price target is
¥5,565.00 60.37%
register free of charge
, the lowest is
¥4,949.00 42.62%
register free of charge
.
A rating was issued by 7 analysts: 6 Analysts recommend Genky Drugstores Co.,ltd. to buy, 1 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Genky Drugstores Co.,ltd. stock has an average upside potential 2027 of . Most analysts recommend the Genky Drugstores Co.,ltd. stock at Purchase.

Sales and Margin forecast 2027, 2028 & 2029

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Jun '26 2027
Estimates
Revenue Billion ¥ 220.64 205.85
9.89% 6.70%
EBITDA Margin 8.21% 9.86%
6.68% 20.07%
Net Margin 3.57% 4.17%
1.42% 16.83%

4 Analysts have issued a sales forecast Genky Drugstores Co.,ltd. 2027 . The average Genky Drugstores Co.,ltd. sales estimate is

¥206b
unlock
. This is
6.70% lower
unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
¥259b 17.37%
unlock
, the lowest is
¥117b 47.19%
unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2026 ¥221b 9.89%
2027
¥206b 6.70%
unlock
2028
¥279b 35.74%
unlock
2029
¥317b 13.43%
unlock

2 Analysts have issued an Genky Drugstores Co.,ltd. EBITDA forecast 2027. The average Genky Drugstores Co.,ltd. EBITDA estimate is

¥20.3b
unlock
. This is
12.05% higher
unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
¥21.1b 16.49%
unlock
, the lowest is
¥19.7b 8.72%
unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2026 ¥18.1b 17.22%
2027
¥20.3b 12.05%
unlock
2028
¥22.9b 12.94%
unlock
2029
¥25.7b 11.89%
unlock

EBITDA Margin

2026 8.21% 6.68%
2027
9.86% 20.07%
unlock
2028
8.21% 16.73%
unlock
2029
8.09% 1.46%
unlock

4 Genky Drugstores Co.,ltd. Analysts have issued a net profit forecast 2027. The average Genky Drugstores Co.,ltd. net profit estimate is

¥8.6b
unlock
. This is
9.08% higher
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
¥9.4b 19.76%
unlock
, the lowest is
¥8.1b 2.29%
unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2026 ¥7.9b 11.45%
2027
¥8.6b 9.08%
unlock
2028
¥9.7b 13.01%
unlock
2029
¥10.9b 12.61%
unlock

Net Margin

2026 3.57% 1.42%
2027
4.17% 16.83%
unlock
2028
3.47% 16.79%
unlock
2029
3.45% 0.58%
unlock

Earnings per share, P/E ratio and EV/sales Estimates 2027, 2028 & 2029

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Jun '26 2027
Estimates
Earnings Per Share ¥ 257.70 281.55
11.06% 9.25%
P/E 12.32
EV/Sales 0.67

4 Analysts have issued a Genky Drugstores Co.,ltd. forecast for earnings per share. The average Genky Drugstores Co.,ltd. EPS is

¥281.55
unlock
. This is
9.31% higher
unlock
than earnings per share in the financial year 2026. The highest EPS forecast is
¥309.12 20.01%
unlock
, the lowest is
¥264.01 2.50%
unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2026 ¥257.70 11.06%
2027
¥281.55 9.25%
unlock
2028
¥318.18 13.01%
unlock
2029
¥358.30 12.61%
unlock

P/E ratio

Current 13.47 34.76%
2027
12.32 8.55%
unlock
2028
10.91 11.44%
unlock
2029
9.68 11.27%
unlock

Based on analysts' sales estimates for 2027, the Genky Drugstores Co.,ltd. stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 0.63
2027
0.67 6.76%
unlock
2028
0.50 26.33%
unlock
2029
0.44 11.85%
unlock

P/S ratio

Current
2027
0.52 7.20%
unlock
2028
0.38 26.34%
unlock
2029
0.34 11.84%
unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today